NSB Advisors’s Celgene Corp CELG Stock Holding History

NSB Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-18,780	Closed	-$2.17M	–	29
2015 Q1	$2.17M	Hold	18,780	–	–	2.7%	9
2014 Q4	$2.1M	Hold	18,780	–	–	2.11%	6
2014 Q3	$1.78M	Hold	18,780	–	–	1.5%	6
2014 Q2	$1.61M	Sell	18,780 -550	-3%	-$41.8K	1.13%	9
2014 Q1	$1.35M	Hold	19,330	–	–	0.87%	11
2013 Q4	$1.63M	Hold	19,330	–	–	0.96%	10
2013 Q3	$1.49M	Hold	19,330	–	–	0.86%	11
2013 Q2	$1.13M	Buy	+19,330	New	+$1.16M	0.63%	13

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

NSB Advisors's CELG Position: Q2 2015 in Review

NSB Advisors sold out of Celgene Corp (CELG) in Q2 2015, closing a stake of 18,780 shares — an estimated $2.17M sold.

NSB Advisors first reported a position in CELG in Q2 2013 and held it in 8 quarters. The position peaked at $2.17M in Q1 2015. 1,201 funds tracked by Wall St. Rank hold CELG as of Q2 2015.

NSB Advisors reported no remaining Celgene Corp position as of Q2 2015 after selling out during the quarter.
NSB Advisors sold 18,780 Celgene Corp shares in Q2 2015, an estimated $2.17M.
NSB Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 8 quarters.
NSB Advisors's Celgene Corp position peaked at $2.17M in Q1 2015.
1,201 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2015.

Based on NSB Advisors's 13F filing for Q2 2015.